GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp1
|
ENSRNOG00000009184 | forkhead box P1 |
Foxj2
|
ENSRNOG00000009000 | forkhead box J2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxp1 | rn6_v1_chr4_-_131694755_131694755 | -0.37 | 1.2e-11 | Click! |
Foxj2 | rn6_v1_chr4_+_155653718_155653718 | -0.35 | 9.9e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_-_64818813 | 65.73 |
ENSRNOT00000009111
ENSRNOT00000086505 |
Aldob
|
aldolase, fructose-bisphosphate B |
chr14_-_19072677 | 63.66 |
ENSRNOT00000060548
|
LOC360919
|
similar to alpha-fetoprotein |
chr2_-_182035032 | 59.95 |
ENSRNOT00000009813
|
Fgb
|
fibrinogen beta chain |
chr4_+_154391647 | 58.39 |
ENSRNOT00000081488
ENSRNOT00000079192 |
Mug1
|
murinoglobulin 1 |
chr13_+_89597138 | 56.69 |
ENSRNOT00000004662
|
Apoa2
|
apolipoprotein A2 |
chr12_+_10636275 | 52.93 |
ENSRNOT00000001285
|
Cyp3a18
|
cytochrome P450, family 3, subfamily a, polypeptide 18 |
chr1_-_263803150 | 51.38 |
ENSRNOT00000017840
|
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr11_+_61605937 | 50.04 |
ENSRNOT00000093455
ENSRNOT00000093242 |
Gramd1c
|
GRAM domain containing 1C |
chr4_+_154505826 | 49.77 |
ENSRNOT00000044408
|
Mug1
|
murinoglobulin 1 |
chr10_+_96639924 | 46.15 |
ENSRNOT00000004756
|
Apoh
|
apolipoprotein H |
chr13_-_80862963 | 44.85 |
ENSRNOT00000004864
|
Fmo3
|
flavin containing monooxygenase 3 |
chr18_+_59748444 | 43.80 |
ENSRNOT00000024752
|
St8sia3
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
chr14_+_22517774 | 43.60 |
ENSRNOT00000047655
|
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr13_-_56877611 | 43.20 |
ENSRNOT00000079040
ENSRNOT00000017195 |
Cfhr1
|
complement factor H-related 1 |
chr7_+_93975451 | 43.04 |
ENSRNOT00000011379
|
Colec10
|
collectin subfamily member 10 |
chr7_-_119689938 | 42.43 |
ENSRNOT00000000200
|
Tmprss6
|
transmembrane protease, serine 6 |
chr10_+_56662242 | 41.98 |
ENSRNOT00000086919
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr10_+_56662561 | 40.87 |
ENSRNOT00000025254
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr13_-_99287887 | 39.78 |
ENSRNOT00000004780
|
Ephx1
|
epoxide hydrolase 1 |
chrX_+_111122552 | 36.87 |
ENSRNOT00000083566
ENSRNOT00000085078 ENSRNOT00000090928 |
Cldn2
|
claudin 2 |
chr1_-_263762785 | 36.62 |
ENSRNOT00000018221
|
Cpn1
|
carboxypeptidase N subunit 1 |
chr5_-_134207847 | 34.87 |
ENSRNOT00000083686
ENSRNOT00000088209 ENSRNOT00000051252 |
Cyp4a2
|
cytochrome P450, family 4, subfamily a, polypeptide 2 |
chr1_-_48360131 | 34.73 |
ENSRNOT00000051927
ENSRNOT00000023116 |
Slc22a2
|
solute carrier family 22 member 2 |
chr13_-_56693968 | 34.61 |
ENSRNOT00000060160
|
AABR07021096.1
|
|
chr13_-_47377703 | 34.32 |
ENSRNOT00000005461
|
C4bpa
|
complement component 4 binding protein, alpha |
chr5_+_137357674 | 33.23 |
ENSRNOT00000092813
|
RGD1305347
|
similar to RIKEN cDNA 2610528J11 |
chr13_+_78805347 | 33.07 |
ENSRNOT00000003748
|
Serpinc1
|
serpin family C member 1 |
chr1_+_83163079 | 32.98 |
ENSRNOT00000077725
ENSRNOT00000034845 |
Cyp2b3
|
cytochrome P450, family 2, subfamily b, polypeptide 3 |
chr1_+_91716383 | 31.47 |
ENSRNOT00000016919
|
Slc7a9
|
solute carrier family 7 member 9 |
chr8_-_49109981 | 31.43 |
ENSRNOT00000019933
|
Ttc36
|
tetratricopeptide repeat domain 36 |
chr4_-_176528110 | 30.91 |
ENSRNOT00000049569
|
Slco1a2
|
solute carrier organic anion transporter family, member 1A2 |
chr2_-_180914940 | 30.32 |
ENSRNOT00000015732
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr10_+_103395511 | 30.21 |
ENSRNOT00000004256
|
Gprc5c
|
G protein-coupled receptor, class C, group 5, member C |
chr6_-_127534247 | 29.72 |
ENSRNOT00000012500
|
Serpina6
|
serpin family A member 6 |
chr2_+_182006242 | 29.19 |
ENSRNOT00000064091
|
Fga
|
fibrinogen alpha chain |
chr4_+_153921115 | 29.14 |
ENSRNOT00000018821
|
Slc6a12
|
solute carrier family 6 member 12 |
chr8_-_85645718 | 28.59 |
ENSRNOT00000032185
|
Gsta2
|
glutathione S-transferase alpha 2 |
chr11_-_81660395 | 28.23 |
ENSRNOT00000048739
|
Fetub
|
fetuin B |
chr12_-_10391270 | 27.94 |
ENSRNOT00000092340
|
Wasf3
|
WAS protein family, member 3 |
chr12_-_39396042 | 27.71 |
ENSRNOT00000001746
|
P2rx7
|
purinergic receptor P2X 7 |
chr5_+_124300477 | 27.57 |
ENSRNOT00000010100
|
C8b
|
complement C8 beta chain |
chr14_+_22375955 | 27.54 |
ENSRNOT00000063915
ENSRNOT00000034784 |
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr6_-_108167185 | 27.16 |
ENSRNOT00000015545
|
Aldh6a1
|
aldehyde dehydrogenase 6 family, member A1 |
chr5_-_19368431 | 26.94 |
ENSRNOT00000012819
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chr7_-_138483612 | 26.90 |
ENSRNOT00000085620
|
Slc38a4
|
solute carrier family 38, member 4 |
chr2_+_54466280 | 26.28 |
ENSRNOT00000033112
|
C6
|
complement C6 |
chr13_-_80702315 | 26.21 |
ENSRNOT00000004577
|
Fmo4
|
flavin containing monooxygenase 4 |
chr1_-_48559162 | 26.12 |
ENSRNOT00000080352
|
Plg
|
plasminogen |
chr9_+_74124016 | 26.03 |
ENSRNOT00000019023
|
Cps1
|
carbamoyl-phosphate synthase 1 |
chr2_-_100249811 | 25.76 |
ENSRNOT00000086760
|
Hnf4g
|
hepatocyte nuclear factor 4, gamma |
chr4_-_154855098 | 25.60 |
ENSRNOT00000041957
|
LOC297568
|
alpha-1-inhibitor III |
chr17_-_43504604 | 25.11 |
ENSRNOT00000083829
ENSRNOT00000066313 |
Slc17a1
|
solute carrier family 17 member 1 |
chr16_+_54153054 | 25.06 |
ENSRNOT00000090644
ENSRNOT00000014248 |
Fgl1
|
fibrinogen-like 1 |
chr12_+_9446940 | 24.57 |
ENSRNOT00000074791
|
Urad
|
ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase |
chr9_+_95501778 | 24.54 |
ENSRNOT00000086805
|
Spp2
|
secreted phosphoprotein 2 |
chr1_-_224389389 | 23.81 |
ENSRNOT00000077408
ENSRNOT00000050010 |
UST4r
|
integral membrane transport protein UST4r |
chr1_-_102780381 | 23.69 |
ENSRNOT00000080132
|
Saa4
|
serum amyloid A4 |
chr16_+_18690246 | 23.53 |
ENSRNOT00000081484
|
Mat1a
|
methionine adenosyltransferase 1A |
chr18_-_24929091 | 23.23 |
ENSRNOT00000019596
|
Proc
|
protein C |
chr2_-_185303610 | 23.22 |
ENSRNOT00000093479
ENSRNOT00000046286 |
NEWGENE_1592020
|
protease, serine 48 |
chr16_+_50152008 | 23.13 |
ENSRNOT00000019237
|
Klkb1
|
kallikrein B1 |
chr4_+_62380914 | 22.76 |
ENSRNOT00000029845
|
Tmem140
|
transmembrane protein 140 |
chr1_+_48273611 | 22.54 |
ENSRNOT00000022254
ENSRNOT00000022068 |
Slc22a1
|
solute carrier family 22 member 1 |
chr5_-_124403195 | 22.38 |
ENSRNOT00000067850
|
C8a
|
complement C8 alpha chain |
chr6_-_127816055 | 22.30 |
ENSRNOT00000013175
|
Serpina3m
|
serine (or cysteine) proteinase inhibitor, clade A, member 3M |
chr1_-_22748422 | 22.23 |
ENSRNOT00000021944
|
Slc18b1
|
solute carrier family 18 member B1 |
chr4_+_154676427 | 20.98 |
ENSRNOT00000019969
ENSRNOT00000087441 |
Mug1
|
murinoglobulin 1 |
chr1_+_250426158 | 20.90 |
ENSRNOT00000067643
|
A1cf
|
APOBEC1 complementation factor |
chr2_+_193724248 | 20.55 |
ENSRNOT00000025249
|
Rptn
|
repetin |
chr3_-_127500709 | 20.30 |
ENSRNOT00000006330
|
Hao1
|
hydroxyacid oxidase 1 |
chr1_+_107344904 | 20.04 |
ENSRNOT00000082582
|
Gas2
|
growth arrest-specific 2 |
chr3_+_5519990 | 19.72 |
ENSRNOT00000070873
ENSRNOT00000007640 |
Adamts13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13 |
chr15_-_42693694 | 19.69 |
ENSRNOT00000022702
|
Gulo
|
gulonolactone (L-) oxidase |
chr5_-_88629491 | 19.57 |
ENSRNOT00000058906
|
Tle1
|
transducin like enhancer of split 1 |
chr1_-_275876329 | 19.42 |
ENSRNOT00000047903
|
Gpam
|
glycerol-3-phosphate acyltransferase, mitochondrial |
chr2_+_222021103 | 19.36 |
ENSRNOT00000086125
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr5_-_173484986 | 19.25 |
ENSRNOT00000064207
ENSRNOT00000055319 |
Ttll10
|
tubulin tyrosine ligase like 10 |
chr1_+_83103925 | 18.78 |
ENSRNOT00000047540
ENSRNOT00000028196 |
Cyp2b2
|
cytochrome P450, family 2, subfamily b, polypeptide 2 |
chr1_+_107262659 | 18.75 |
ENSRNOT00000022499
|
Gas2
|
growth arrest-specific 2 |
chr4_-_98995590 | 18.64 |
ENSRNOT00000008698
|
Thnsl2
|
threonine synthase-like 2 |
chr13_-_102721218 | 18.57 |
ENSRNOT00000005459
|
Marc1
|
mitochondrial amidoxime reducing component 1 |
chr2_+_200572502 | 18.51 |
ENSRNOT00000074666
|
Zfp697
|
zinc finger protein 697 |
chr20_+_3677474 | 18.51 |
ENSRNOT00000047663
|
Mt1m
|
metallothionein 1M |
chr4_+_154309426 | 18.49 |
ENSRNOT00000019346
|
A2m
|
alpha-2-macroglobulin |
chr2_-_138833933 | 18.29 |
ENSRNOT00000013343
|
Pcdh18
|
protocadherin 18 |
chr1_-_148119857 | 18.08 |
ENSRNOT00000040325
|
LOC100361547
|
Cytochrome P450, family 2, subfamily c, polypeptide 7-like |
chr11_-_81639872 | 18.01 |
ENSRNOT00000047595
ENSRNOT00000090031 ENSRNOT00000081864 |
Hrg
|
histidine-rich glycoprotein |
chr2_+_200397967 | 17.89 |
ENSRNOT00000025821
|
Reg4
|
regenerating family member 4 |
chr7_+_141053876 | 17.84 |
ENSRNOT00000084674
|
Tmbim6
|
transmembrane BAX inhibitor motif containing 6 |
chr6_-_125590049 | 17.81 |
ENSRNOT00000006371
|
Tc2n
|
tandem C2 domains, nuclear |
chr7_+_2689501 | 17.60 |
ENSRNOT00000041341
|
Apof
|
apolipoprotein F |
chr13_-_56763981 | 17.53 |
ENSRNOT00000087916
|
LOC100361907
|
complement factor H-related protein B |
chr13_-_47397890 | 17.49 |
ENSRNOT00000005505
|
C4bpb
|
complement component 4 binding protein, beta |
chr14_-_8432195 | 17.45 |
ENSRNOT00000089800
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr7_-_68512397 | 17.40 |
ENSRNOT00000058036
|
Slc16a7
|
solute carrier family 16 member 7 |
chr11_-_32550539 | 17.38 |
ENSRNOT00000002715
|
Rcan1
|
regulator of calcineurin 1 |
chr15_-_50425900 | 17.28 |
ENSRNOT00000058715
|
Adam28
|
ADAM metallopeptidase domain 28 |
chr13_+_91080341 | 17.24 |
ENSRNOT00000000058
|
Crp
|
C-reactive protein |
chr13_-_111972603 | 17.10 |
ENSRNOT00000007870
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1 |
chr2_-_198016898 | 16.75 |
ENSRNOT00000025523
|
Car14
|
carbonic anhydrase 14 |
chr10_+_56824505 | 16.72 |
ENSRNOT00000067128
|
Slc16a11
|
solute carrier family 16, member 11 |
chr11_-_87924816 | 16.64 |
ENSRNOT00000031819
|
Serpind1
|
serpin family D member 1 |
chr16_-_7026540 | 16.50 |
ENSRNOT00000051751
|
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr7_-_30105132 | 16.49 |
ENSRNOT00000091227
|
Nr1h4
|
nuclear receptor subfamily 1, group H, member 4 |
chr4_-_15505362 | 16.32 |
ENSRNOT00000009763
|
Hgf
|
hepatocyte growth factor |
chr15_-_28313841 | 16.11 |
ENSRNOT00000085897
|
Ndrg2
|
NDRG family member 2 |
chr9_-_23352668 | 16.05 |
ENSRNOT00000075279
|
Mut
|
methylmalonyl CoA mutase |
chr7_+_99142450 | 16.01 |
ENSRNOT00000079036
ENSRNOT00000091923 |
LOC108348266
|
cytochrome P450 2B1 |
chr3_+_2288667 | 15.94 |
ENSRNOT00000012289
|
Entpd8
|
ectonucleoside triphosphate diphosphohydrolase 8 |
chr14_-_19191863 | 15.91 |
ENSRNOT00000003921
|
Alb
|
albumin |
chr4_-_117790350 | 15.70 |
ENSRNOT00000088557
|
Nat8b
|
N-acetyltransferase 8B |
chr19_+_15081158 | 15.54 |
ENSRNOT00000074070
|
Ces1f
|
carboxylesterase 1F |
chr2_-_158133861 | 15.49 |
ENSRNOT00000090700
|
Veph1
|
ventricular zone expressed PH domain-containing 1 |
chr2_+_200603426 | 15.48 |
ENSRNOT00000072189
|
LOC102550892
|
zinc finger protein 697-like |
chr1_+_220114228 | 15.12 |
ENSRNOT00000026718
|
Ctsf
|
cathepsin F |
chr7_+_71057911 | 15.10 |
ENSRNOT00000037218
|
Rdh16
|
retinol dehydrogenase 16 (all-trans) |
chr10_-_82852660 | 15.09 |
ENSRNOT00000005641
|
Pdk2
|
pyruvate dehydrogenase kinase 2 |
chr8_-_21901829 | 15.01 |
ENSRNOT00000027963
|
Angptl6
|
angiopoietin-like 6 |
chr4_-_117607428 | 14.85 |
ENSRNOT00000021243
|
LOC103690139
|
probable N-acetyltransferase CML6 |
chr7_-_129970550 | 14.84 |
ENSRNOT00000055879
|
Mlc1
|
megalencephalic leukoencephalopathy with subcortical cysts 1 |
chr1_-_167911961 | 14.80 |
ENSRNOT00000025097
|
Olr59
|
olfactory receptor 59 |
chr7_+_11490852 | 14.76 |
ENSRNOT00000044484
|
Creb3l3
|
cAMP responsive element binding protein 3-like 3 |
chr1_+_264741911 | 14.71 |
ENSRNOT00000019956
|
Sema4g
|
semaphorin 4G |
chr3_-_101474890 | 14.63 |
ENSRNOT00000091869
|
Bbox1
|
gamma-butyrobetaine hydroxylase 1 |
chr2_-_173800761 | 14.50 |
ENSRNOT00000039524
|
Wdr49
|
WD repeat domain 49 |
chr6_+_56846789 | 14.44 |
ENSRNOT00000032108
|
Agmo
|
alkylglycerol monooxygenase |
chr8_+_52127632 | 14.42 |
ENSRNOT00000079797
|
Cadm1
|
cell adhesion molecule 1 |
chr1_+_15642153 | 14.30 |
ENSRNOT00000079845
|
Map7
|
microtubule-associated protein 7 |
chr13_-_56462834 | 14.20 |
ENSRNOT00000032122
|
Crb1
|
crumbs 1, cell polarity complex component |
chr2_+_58462949 | 14.17 |
ENSRNOT00000080618
|
Nadk2
|
NAD kinase 2, mitochondrial |
chr15_+_34234193 | 14.17 |
ENSRNOT00000077584
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr15_+_34234755 | 14.02 |
ENSRNOT00000059987
|
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr18_-_35071619 | 13.92 |
ENSRNOT00000075695
|
LOC100911558
|
serine protease inhibitor Kazal-type 3-like |
chr8_+_85503224 | 13.81 |
ENSRNOT00000012348
|
Gsta4
|
glutathione S-transferase alpha 4 |
chr16_-_39476025 | 13.75 |
ENSRNOT00000014312
|
Gpm6a
|
glycoprotein m6a |
chr9_-_27452902 | 13.67 |
ENSRNOT00000018325
|
Gsta1
|
glutathione S-transferase alpha 1 |
chr7_-_142318620 | 13.58 |
ENSRNOT00000006351
|
Cela1
|
chymotrypsin-like elastase family, member 1 |
chr4_-_115332052 | 13.55 |
ENSRNOT00000017643
|
Clec4f
|
C-type lectin domain family 4, member F |
chr17_-_13393243 | 13.54 |
ENSRNOT00000018252
|
Gadd45g
|
growth arrest and DNA-damage-inducible, gamma |
chr19_+_60104804 | 13.49 |
ENSRNOT00000078559
|
Pard3
|
par-3 family cell polarity regulator |
chr1_+_32199810 | 13.44 |
ENSRNOT00000036714
|
Slc6a19
|
solute carrier family 6 member 19 |
chr7_-_66172360 | 13.43 |
ENSRNOT00000005537
|
Fam19a2
|
family with sequence similarity 19 member A2, C-C motif chemokine like |
chr4_+_22082194 | 13.33 |
ENSRNOT00000091799
|
Crot
|
carnitine O-octanoyltransferase |
chr3_+_142383278 | 13.15 |
ENSRNOT00000017742
|
Foxa2
|
forkhead box A2 |
chr6_-_95502775 | 13.12 |
ENSRNOT00000074990
ENSRNOT00000034289 |
Dhrs7l1
|
dehydrogenase/reductase (SDR family) member 7-like 1 |
chr5_+_124442293 | 13.12 |
ENSRNOT00000041922
|
RGD1564074
|
similar to novel protein |
chr6_-_99843245 | 12.92 |
ENSRNOT00000080270
|
Gpx2
|
glutathione peroxidase 2 |
chr8_-_22937909 | 12.89 |
ENSRNOT00000015684
|
Tmem205
|
transmembrane protein 205 |
chr6_+_128073344 | 12.82 |
ENSRNOT00000014073
|
LOC500712
|
Ab1-233 |
chr18_+_38292701 | 12.79 |
ENSRNOT00000037796
|
Scgb3a2
|
secretoglobin, family 3A, member 2 |
chr16_-_39476384 | 12.78 |
ENSRNOT00000092968
|
Gpm6a
|
glycoprotein m6a |
chr10_-_38774449 | 12.67 |
ENSRNOT00000049820
|
Leap2
|
liver-expressed antimicrobial peptide 2 |
chr11_+_61609370 | 12.64 |
ENSRNOT00000088880
ENSRNOT00000082533 |
Gramd1c
|
GRAM domain containing 1C |
chr5_+_152290084 | 12.60 |
ENSRNOT00000089849
|
Aim1l
|
absent in melanoma 1-like |
chr10_-_94979259 | 12.51 |
ENSRNOT00000018394
|
Polg2
|
DNA polymerase gamma 2, accessory subunit |
chr4_+_139670092 | 12.48 |
ENSRNOT00000008879
|
Lrrn1
|
leucine rich repeat neuronal 1 |
chr6_-_47890033 | 12.42 |
ENSRNOT00000011290
|
Colec11
|
collectin sub-family member 11 |
chr1_+_141488272 | 12.38 |
ENSRNOT00000034042
|
Wdr93
|
WD repeat domain 93 |
chr3_-_79282493 | 12.37 |
ENSRNOT00000049832
|
Ptprj
|
protein tyrosine phosphatase, receptor type, J |
chr10_+_86399827 | 12.36 |
ENSRNOT00000009299
|
Grb7
|
growth factor receptor bound protein 7 |
chr1_+_166428761 | 12.34 |
ENSRNOT00000085555
|
Stard10
|
StAR-related lipid transfer domain containing 10 |
chr5_-_4975436 | 12.22 |
ENSRNOT00000062006
|
Xkr9
|
XK related 9 |
chr2_+_58724855 | 12.22 |
ENSRNOT00000089609
|
Capsl
|
calcyphosine-like |
chr13_+_91054974 | 12.17 |
ENSRNOT00000091089
|
Crp
|
C-reactive protein |
chr2_+_53109684 | 12.17 |
ENSRNOT00000086590
|
Selenop
|
selenoprotein P |
chr1_-_82344345 | 12.11 |
ENSRNOT00000051892
ENSRNOT00000090629 ENSRNOT00000029487 ENSRNOT00000027933 |
Ceacam1
|
carcinoembryonic antigen related cell adhesion molecule 1 |
chr13_+_75177965 | 11.98 |
ENSRNOT00000007321
|
Sec16b
|
SEC16 homolog B, endoplasmic reticulum export factor |
chr4_+_163293724 | 11.77 |
ENSRNOT00000077356
|
Gabarapl1
|
GABA type A receptor associated protein like 1 |
chr15_+_28023018 | 11.72 |
ENSRNOT00000090272
|
Rnase4
|
ribonuclease A family member 4 |
chr11_-_11585078 | 11.72 |
ENSRNOT00000088878
|
Robo2
|
roundabout guidance receptor 2 |
chr4_+_41364441 | 11.61 |
ENSRNOT00000087146
|
Foxp2
|
forkhead box P2 |
chr6_+_47940183 | 11.51 |
ENSRNOT00000011951
|
Adi1
|
acireductone dioxygenase 1 |
chr4_+_57855416 | 11.40 |
ENSRNOT00000029608
|
Cpa2
|
carboxypeptidase A2 |
chr19_+_22450030 | 11.38 |
ENSRNOT00000021739
|
Neto2
|
neuropilin and tolloid like 2 |
chr19_-_21492468 | 11.27 |
ENSRNOT00000087660
ENSRNOT00000048345 ENSRNOT00000020770 |
Lonp2
|
lon peptidase 2, peroxisomal |
chr5_-_115222075 | 11.24 |
ENSRNOT00000058163
ENSRNOT00000012503 |
LOC100912642
|
cytochrome P450 2J3-like |
chr20_-_9855443 | 11.19 |
ENSRNOT00000090275
ENSRNOT00000066266 |
Tff3
|
trefoil factor 3 |
chr1_-_104024682 | 11.19 |
ENSRNOT00000056081
|
Mrgprx1
|
MAS-related GPR, member X1 |
chr8_+_52127399 | 11.19 |
ENSRNOT00000052392
|
Cadm1
|
cell adhesion molecule 1 |
chr8_+_57886168 | 11.13 |
ENSRNOT00000039336
|
Exph5
|
exophilin 5 |
chr2_-_188596222 | 11.11 |
ENSRNOT00000027920
|
Efna1
|
ephrin A1 |
chr2_+_18354542 | 11.08 |
ENSRNOT00000042958
|
Hapln1
|
hyaluronan and proteoglycan link protein 1 |
chr9_+_4107246 | 10.93 |
ENSRNOT00000078212
|
AABR07066160.1
|
|
chr15_-_23969011 | 10.92 |
ENSRNOT00000014821
|
Gch1
|
GTP cyclohydrolase 1 |
chr3_+_117422704 | 10.92 |
ENSRNOT00000085647
|
Slc12a1
|
solute carrier family 12 member 1 |
chr3_-_94657377 | 10.87 |
ENSRNOT00000077484
|
Tcp11l1
|
t-complex 11 like 1 |
chr2_-_113616766 | 10.70 |
ENSRNOT00000016858
ENSRNOT00000074723 |
Tmem212
|
transmembrane protein 212 |
chr11_+_62584959 | 10.68 |
ENSRNOT00000071065
|
Gramd1c
|
GRAM domain containing 1C |
chr6_-_80102635 | 10.53 |
ENSRNOT00000084611
|
Sec23a
|
Sec23 homolog A, coat complex II component |
chr8_+_49676540 | 10.35 |
ENSRNOT00000022032
ENSRNOT00000082205 |
Fxyd6
|
FXYD domain-containing ion transport regulator 6 |
chr1_-_150395415 | 10.32 |
ENSRNOT00000018592
|
Folh1
|
folate hydrolase 1 |
chr6_-_22138286 | 10.28 |
ENSRNOT00000007607
|
Yipf4
|
Yip1 domain family, member 4 |
chr15_-_88036354 | 10.28 |
ENSRNOT00000014747
|
Ednrb
|
endothelin receptor type B |
chr13_-_37287458 | 10.27 |
ENSRNOT00000003391
|
Insig2
|
insulin induced gene 2 |
chr5_-_127661028 | 10.21 |
ENSRNOT00000015466
|
Podn
|
podocan |
chr2_+_58462588 | 10.19 |
ENSRNOT00000083799
|
Nadk2
|
NAD kinase 2, mitochondrial |
chr3_-_44086006 | 10.16 |
ENSRNOT00000034449
ENSRNOT00000082604 |
Ermn
|
ermin |
chr14_+_89253373 | 10.12 |
ENSRNOT00000035922
|
LOC688553
|
hypothetical protein LOC688553 |
chr12_+_47407811 | 10.12 |
ENSRNOT00000001565
|
Hnf1a
|
HNF1 homeobox A |
chr8_-_110813000 | 10.05 |
ENSRNOT00000010634
|
Ephb1
|
Eph receptor B1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.9 | 68.7 | GO:0006116 | NADH oxidation(GO:0006116) |
19.8 | 79.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
18.9 | 56.7 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) diacylglycerol catabolic process(GO:0046340) |
18.4 | 92.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
17.3 | 51.8 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
14.6 | 43.8 | GO:1990743 | protein sialylation(GO:1990743) |
11.0 | 32.9 | GO:0006574 | valine catabolic process(GO:0006574) |
9.2 | 27.7 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) NAD transport(GO:0043132) regulation of bleb assembly(GO:1904170) |
8.8 | 26.3 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
8.7 | 34.9 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
8.7 | 26.1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
7.9 | 31.5 | GO:0015811 | L-cystine transport(GO:0015811) |
7.3 | 36.6 | GO:0030070 | insulin processing(GO:0030070) |
7.3 | 29.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
6.7 | 66.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
6.5 | 19.4 | GO:0032978 | protein insertion into membrane from inner side(GO:0032978) |
6.5 | 19.4 | GO:0006214 | thymidine catabolic process(GO:0006214) pyrimidine deoxyribonucleoside catabolic process(GO:0046127) |
6.4 | 19.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
6.2 | 24.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
5.9 | 17.8 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
5.8 | 80.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
5.7 | 17.1 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
5.5 | 16.5 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
5.2 | 20.9 | GO:0016554 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) cytidine to uridine editing(GO:0016554) |
5.2 | 26.0 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
5.1 | 20.3 | GO:0009441 | glycolate metabolic process(GO:0009441) |
5.0 | 90.3 | GO:0042730 | fibrinolysis(GO:0042730) |
4.9 | 19.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
4.9 | 29.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
4.9 | 24.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
4.7 | 14.0 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
4.6 | 23.2 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
4.6 | 18.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
4.6 | 18.5 | GO:1990402 | embryonic liver development(GO:1990402) |
4.5 | 27.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
4.5 | 120.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
4.4 | 22.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
4.4 | 13.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
4.4 | 21.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.3 | 30.3 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
4.1 | 16.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
4.0 | 7.9 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.9 | 11.6 | GO:0032218 | riboflavin transport(GO:0032218) |
3.8 | 42.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
3.8 | 11.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
3.7 | 18.6 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
3.7 | 14.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
3.6 | 10.9 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
3.5 | 10.5 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
3.5 | 17.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
3.3 | 39.8 | GO:0034312 | diol biosynthetic process(GO:0034312) |
3.2 | 9.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
3.1 | 12.6 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
3.1 | 27.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.0 | 18.2 | GO:0070541 | response to platinum ion(GO:0070541) |
3.0 | 12.1 | GO:0007172 | signal complex assembly(GO:0007172) |
2.9 | 50.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
2.8 | 30.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
2.8 | 11.1 | GO:0014028 | notochord formation(GO:0014028) |
2.7 | 13.7 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
2.7 | 5.4 | GO:0060849 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
2.7 | 10.8 | GO:0051692 | cellular oligosaccharide catabolic process(GO:0051692) |
2.7 | 152.6 | GO:0006953 | acute-phase response(GO:0006953) |
2.7 | 13.3 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
2.7 | 8.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.6 | 23.8 | GO:0015747 | urate transport(GO:0015747) |
2.5 | 10.1 | GO:0035565 | regulation of pronephros size(GO:0035565) |
2.5 | 25.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
2.5 | 4.9 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
2.4 | 14.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.4 | 16.7 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
2.3 | 7.0 | GO:2000426 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) negative regulation of apoptotic cell clearance(GO:2000426) |
2.3 | 36.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
2.2 | 22.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.2 | 8.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
2.2 | 15.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
2.1 | 62.2 | GO:0017144 | drug metabolic process(GO:0017144) |
2.1 | 4.3 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
2.1 | 6.4 | GO:1901492 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) positive regulation of lymphangiogenesis(GO:1901492) |
2.0 | 12.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.0 | 6.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
2.0 | 5.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
1.9 | 25.1 | GO:0046415 | urate metabolic process(GO:0046415) |
1.9 | 11.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
1.9 | 1.9 | GO:1904412 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of cardiac ventricle development(GO:1904412) |
1.9 | 5.7 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
1.9 | 9.3 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
1.9 | 3.7 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.9 | 16.7 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
1.8 | 21.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.8 | 5.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.8 | 10.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.7 | 3.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.7 | 5.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.7 | 5.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.7 | 8.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.6 | 4.8 | GO:1901252 | negative regulation of long term synaptic depression(GO:1900453) regulation of intracellular transport of viral material(GO:1901252) |
1.6 | 11.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.6 | 6.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.5 | 4.6 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.5 | 6.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.5 | 3.0 | GO:0010157 | response to chlorate(GO:0010157) |
1.5 | 1.5 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
1.5 | 11.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.4 | 7.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) alveolar secondary septum development(GO:0061144) |
1.4 | 5.7 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
1.4 | 8.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
1.4 | 1.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.4 | 8.2 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 4.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
1.4 | 8.1 | GO:0010193 | response to ozone(GO:0010193) |
1.3 | 5.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
1.3 | 6.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.3 | 2.7 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.3 | 8.9 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
1.3 | 6.3 | GO:0061743 | motor learning(GO:0061743) |
1.3 | 13.8 | GO:0009635 | response to herbicide(GO:0009635) |
1.2 | 7.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.2 | 17.4 | GO:0007614 | short-term memory(GO:0007614) |
1.2 | 6.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.2 | 19.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
1.2 | 4.8 | GO:0009597 | detection of virus(GO:0009597) |
1.2 | 4.8 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.2 | 15.3 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
1.2 | 3.5 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.2 | 9.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.2 | 7.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.2 | 6.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.1 | 13.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.1 | 2.3 | GO:0042335 | cuticle development(GO:0042335) |
1.1 | 9.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.1 | 4.5 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
1.1 | 3.4 | GO:2000424 | regulation of eosinophil chemotaxis(GO:2000422) positive regulation of eosinophil chemotaxis(GO:2000424) |
1.1 | 11.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.1 | 17.7 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
1.1 | 23.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.1 | 16.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
1.1 | 8.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
1.1 | 19.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.1 | 3.2 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
1.1 | 7.4 | GO:0030035 | microspike assembly(GO:0030035) |
1.0 | 10.4 | GO:0048102 | autophagic cell death(GO:0048102) |
1.0 | 6.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.0 | 11.3 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.0 | 5.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.0 | 12.1 | GO:0034063 | stress granule assembly(GO:0034063) |
1.0 | 3.0 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.0 | 10.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.0 | 13.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.0 | 3.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
1.0 | 5.7 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.0 | 1.9 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.9 | 4.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.9 | 8.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.9 | 6.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.9 | 6.4 | GO:0022605 | oogenesis stage(GO:0022605) |
0.9 | 10.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.9 | 6.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.9 | 1.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.9 | 1.8 | GO:2000974 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.9 | 7.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.9 | 7.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.8 | 13.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.8 | 3.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.8 | 13.4 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.8 | 4.1 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
0.8 | 2.5 | GO:1903595 | pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) positive regulation of histamine secretion by mast cell(GO:1903595) |
0.8 | 3.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.8 | 23.6 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.8 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 8.4 | GO:0051132 | NK T cell activation(GO:0051132) |
0.8 | 10.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 3.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 25.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.7 | 5.2 | GO:1901631 | positive regulation of presynaptic membrane organization(GO:1901631) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.7 | 7.3 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 20.5 | GO:0035864 | response to potassium ion(GO:0035864) |
0.7 | 5.8 | GO:0015679 | plasma membrane copper ion transport(GO:0015679) |
0.7 | 2.2 | GO:2000682 | positive regulation of rubidium ion transport(GO:2000682) positive regulation of rubidium ion transmembrane transporter activity(GO:2000688) |
0.7 | 7.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) retinal rod cell development(GO:0046548) |
0.7 | 12.2 | GO:0010269 | response to selenium ion(GO:0010269) |
0.7 | 3.6 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.7 | 1.4 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.7 | 4.9 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.7 | 7.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 2.1 | GO:0098880 | maintenance of postsynaptic specialization structure(GO:0098880) maintenance of postsynaptic density structure(GO:0099562) |
0.7 | 4.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.7 | 9.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 19.9 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.7 | 1.4 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.7 | 2.1 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.7 | 2.0 | GO:0021570 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
0.7 | 6.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 2.7 | GO:0030242 | pexophagy(GO:0030242) |
0.7 | 3.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.7 | 1.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.7 | 4.6 | GO:0010041 | response to iron(III) ion(GO:0010041) |
0.7 | 2.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.7 | 2.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.6 | 4.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 8.9 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.6 | 1.9 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.6 | 3.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.6 | 5.6 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.6 | 16.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.6 | 20.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.6 | 3.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.6 | 3.6 | GO:0008050 | female courtship behavior(GO:0008050) |
0.6 | 1.8 | GO:0051012 | microtubule sliding(GO:0051012) |
0.6 | 1.8 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.6 | 5.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.6 | 20.8 | GO:0060612 | adipose tissue development(GO:0060612) |
0.6 | 1.8 | GO:0009177 | L-serine catabolic process(GO:0006565) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.6 | 4.1 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.6 | 7.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.6 | 2.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.6 | 3.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 3.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 2.8 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.6 | 7.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.6 | 12.2 | GO:0019835 | cytolysis(GO:0019835) |
0.6 | 5.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.5 | 1.6 | GO:0071387 | cellular response to cortisol stimulus(GO:0071387) |
0.5 | 8.6 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.5 | 7.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 29.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.5 | 2.6 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.5 | 2.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.5 | 13.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 3.6 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.5 | 2.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.5 | 0.5 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.5 | 10.5 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.5 | 1.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 13.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.5 | 1.9 | GO:0031179 | peptide modification(GO:0031179) |
0.5 | 4.8 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.5 | 6.6 | GO:0097286 | iron ion import(GO:0097286) |
0.5 | 7.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.5 | 1.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 2.8 | GO:0061072 | embryonic retina morphogenesis in camera-type eye(GO:0060059) iris morphogenesis(GO:0061072) |
0.5 | 2.8 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 6.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.5 | 2.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.5 | 1.8 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 1.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.5 | 2.7 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.4 | 1.3 | GO:0060556 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) regulation of vitamin D biosynthetic process(GO:0060556) |
0.4 | 1.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.4 | 2.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.4 | 2.2 | GO:0001582 | detection of chemical stimulus involved in sensory perception of sweet taste(GO:0001582) |
0.4 | 3.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 1.7 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.4 | 28.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.4 | 3.8 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.4 | 1.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 3.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 0.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 6.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 3.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.4 | 14.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.4 | 4.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 9.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.4 | 5.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.4 | 2.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 2.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.4 | 2.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 29.1 | GO:0007416 | synapse assembly(GO:0007416) |
0.4 | 79.3 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.4 | 5.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.4 | 2.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.3 | 1.0 | GO:0048749 | compound eye development(GO:0048749) |
0.3 | 3.1 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) myelin maintenance(GO:0043217) |
0.3 | 1.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 3.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 1.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 1.3 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 1.6 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.3 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.3 | 13.1 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
0.3 | 3.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 8.3 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 1.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.3 | 0.6 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.3 | 1.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 0.9 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.3 | 9.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.3 | 5.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 8.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 13.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 2.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.3 | 1.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 2.5 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.3 | 8.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.3 | 3.0 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 2.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.3 | 7.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.2 | 25.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 2.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 1.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 2.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.2 | 2.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 5.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 4.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 14.5 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 1.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 1.2 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 0.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.2 | 4.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 3.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 3.1 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.2 | 0.8 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 1.5 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 1.9 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 3.7 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.2 | 0.6 | GO:0031989 | bombesin receptor signaling pathway(GO:0031989) |
0.2 | 4.8 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 3.6 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.2 | 0.7 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 1.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 2.3 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.2 | 1.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 6.9 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.2 | 1.9 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 1.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 2.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 3.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 2.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.2 | 1.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.2 | 2.5 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.2 | 0.6 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 29.6 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.1 | 0.4 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.1 | 0.4 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.1 | 0.6 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.4 | GO:0045575 | basophil activation(GO:0045575) |
0.1 | 2.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 2.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 3.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 1.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 2.2 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 1.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 1.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 4.5 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 2.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.1 | GO:0032401 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.1 | 0.3 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 0.3 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 8.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.6 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:2000769 | regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) |
0.1 | 0.8 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 1.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.7 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 119.3 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 1.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.2 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 1.0 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.1 | 3.2 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) |
0.1 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.9 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.6 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 1.5 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 1.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.0 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 3.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 3.8 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 1.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 1.6 | GO:0051693 | actin filament capping(GO:0051693) |
0.0 | 0.3 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.7 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 1.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 1.0 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 1.2 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.1 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.0 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.4 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 3.2 | GO:0008202 | steroid metabolic process(GO:0008202) |
0.0 | 0.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 0.2 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.0 | 1.1 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) positive regulation of alcohol biosynthetic process(GO:1902932) |
0.0 | 0.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.1 | 65.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
11.1 | 89.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
10.9 | 76.2 | GO:0005579 | membrane attack complex(GO:0005579) |
8.8 | 26.5 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
7.9 | 102.8 | GO:0042627 | chylomicron(GO:0042627) |
7.0 | 35.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
5.1 | 20.5 | GO:0061474 | phagolysosome membrane(GO:0061474) |
4.6 | 13.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
4.5 | 13.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.9 | 23.6 | GO:0033269 | internode region of axon(GO:0033269) |
3.5 | 17.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
3.4 | 10.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
3.1 | 9.2 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
3.0 | 20.9 | GO:0045293 | mRNA editing complex(GO:0045293) |
2.7 | 24.5 | GO:0032059 | bleb(GO:0032059) |
2.4 | 31.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.3 | 265.9 | GO:0072562 | blood microparticle(GO:0072562) |
1.6 | 42.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.6 | 25.6 | GO:0070852 | cell body fiber(GO:0070852) |
1.3 | 6.6 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.3 | 16.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.2 | 4.9 | GO:0036156 | inner dynein arm(GO:0036156) |
1.2 | 19.2 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.1 | 4.6 | GO:0097513 | myosin II filament(GO:0097513) |
1.1 | 7.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.1 | 3.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.1 | 4.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
1.1 | 28.1 | GO:0001533 | cornified envelope(GO:0001533) |
1.0 | 47.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.0 | 5.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.9 | 25.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.9 | 22.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.9 | 44.5 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.9 | 9.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.9 | 6.1 | GO:0090543 | Flemming body(GO:0090543) |
0.8 | 2.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.8 | 5.6 | GO:0043203 | axon hillock(GO:0043203) |
0.8 | 8.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.8 | 2.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.8 | 10.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.7 | 8.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.7 | 5.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.7 | 2.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 19.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 1.4 | GO:0044308 | axonal spine(GO:0044308) |
0.7 | 5.4 | GO:0044305 | calyx of Held(GO:0044305) |
0.7 | 502.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.6 | 3.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.6 | 3.8 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 7.0 | GO:0044754 | autolysosome(GO:0044754) |
0.6 | 6.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 6.8 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 9.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.6 | 22.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 2.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.6 | 1.8 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.6 | 10.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.6 | 4.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.6 | 11.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.6 | 40.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.5 | 20.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 2.1 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.5 | 5.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.5 | 27.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 11.1 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 9.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 2.2 | GO:1903768 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
0.4 | 3.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 5.8 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 1.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 3.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.4 | 7.0 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 3.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 13.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.4 | 1.8 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 4.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 5.1 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 14.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 42.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 39.6 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 17.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 5.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.3 | 7.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 11.0 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 8.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.3 | 4.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 15.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 7.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 8.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 1.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 28.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.3 | 8.5 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 266.7 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.3 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 3.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 3.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 11.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 2.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 2.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.2 | 3.7 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 4.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.2 | 1.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 2.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 10.4 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 7.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.2 | 9.5 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.2 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 11.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.2 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 16.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 1.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 0.5 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 205.8 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 9.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 7.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 18.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.6 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.1 | 1.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 11.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.6 | GO:0070449 | elongin complex(GO:0070449) |
0.1 | 0.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.6 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.3 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.1 | 7.0 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 3.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 2.1 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 22.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.7 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.7 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 20.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.1 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.8 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 78.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 1.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.7 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 4.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 1.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.1 | 57.3 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
18.9 | 56.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
15.4 | 46.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
14.6 | 43.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
11.6 | 34.9 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
10.1 | 30.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
10.0 | 70.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
8.0 | 39.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
7.9 | 31.5 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
7.8 | 23.5 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
7.7 | 23.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
6.8 | 20.4 | GO:0070905 | serine binding(GO:0070905) |
6.5 | 19.4 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
6.5 | 19.4 | GO:0017113 | dihydrouracil dehydrogenase (NAD+) activity(GO:0004159) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
6.4 | 19.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
5.8 | 69.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
5.7 | 40.0 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
5.7 | 17.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
5.0 | 14.9 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
4.9 | 29.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
4.7 | 18.8 | GO:0019959 | interleukin-8 binding(GO:0019959) |
4.7 | 42.2 | GO:0046790 | virion binding(GO:0046790) |
4.6 | 18.6 | GO:0008940 | nitrate reductase activity(GO:0008940) |
4.5 | 120.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
4.5 | 17.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
4.4 | 13.3 | GO:0008458 | carnitine O-octanoyltransferase activity(GO:0008458) O-octanoyltransferase activity(GO:0016414) |
4.3 | 17.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.1 | 16.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
4.1 | 16.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
4.0 | 75.9 | GO:1900750 | oligopeptide binding(GO:1900750) |
4.0 | 83.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
3.9 | 11.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
3.9 | 30.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
3.8 | 56.6 | GO:0001848 | complement binding(GO:0001848) |
3.5 | 17.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
3.2 | 19.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.1 | 9.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
3.1 | 27.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
3.0 | 23.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.0 | 91.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
2.9 | 324.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.8 | 11.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.7 | 13.5 | GO:0005534 | galactose binding(GO:0005534) |
2.6 | 10.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
2.6 | 28.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
2.5 | 20.1 | GO:0031419 | cobalamin binding(GO:0031419) |
2.5 | 7.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.4 | 29.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
2.3 | 16.1 | GO:0097001 | ceramide binding(GO:0097001) |
2.2 | 15.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
2.2 | 42.5 | GO:0005537 | mannose binding(GO:0005537) |
2.2 | 26.1 | GO:1990405 | protein antigen binding(GO:1990405) |
2.1 | 14.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
2.0 | 5.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
1.9 | 49.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
1.9 | 5.7 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
1.9 | 5.7 | GO:0032810 | sterol response element binding(GO:0032810) |
1.9 | 7.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.8 | 21.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.8 | 5.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.7 | 5.2 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
1.7 | 5.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.7 | 8.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.6 | 8.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.6 | 4.8 | GO:0017042 | glycosylceramidase activity(GO:0017042) |
1.6 | 10.9 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.6 | 9.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.6 | 7.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
1.5 | 6.2 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.5 | 6.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.5 | 12.2 | GO:0008430 | selenium binding(GO:0008430) |
1.5 | 33.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.5 | 6.0 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.5 | 25.2 | GO:0016595 | glutamate binding(GO:0016595) |
1.5 | 4.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.5 | 2.9 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.4 | 8.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.4 | 17.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.3 | 5.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
1.3 | 11.8 | GO:0030957 | Tat protein binding(GO:0030957) |
1.3 | 13.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.3 | 10.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.2 | 5.0 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
1.2 | 3.7 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.2 | 3.6 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.2 | 6.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.2 | 9.3 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.1 | 3.3 | GO:0051425 | PTB domain binding(GO:0051425) |
1.1 | 3.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
1.1 | 29.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
1.1 | 6.3 | GO:0034711 | inhibin binding(GO:0034711) |
1.0 | 16.4 | GO:0015643 | toxic substance binding(GO:0015643) |
1.0 | 3.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
1.0 | 15.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
1.0 | 6.9 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.0 | 7.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.0 | 9.7 | GO:0019808 | polyamine binding(GO:0019808) |
1.0 | 4.8 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
1.0 | 12.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.9 | 4.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.9 | 61.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.9 | 3.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.9 | 2.7 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.9 | 23.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.9 | 17.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.8 | 2.5 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.8 | 11.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 3.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.8 | 6.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.8 | 3.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.8 | 4.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 6.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.8 | 9.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.8 | 2.3 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
0.8 | 8.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.7 | 19.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.7 | 15.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.7 | 3.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 9.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 10.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.7 | 14.8 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.7 | 37.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.7 | 13.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.7 | 4.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.7 | 5.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.7 | 16.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 13.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.6 | 1.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.6 | 1.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.6 | 3.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 6.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 23.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.6 | 5.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.6 | 9.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.6 | 8.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.6 | 51.3 | GO:0051087 | chaperone binding(GO:0051087) |
0.6 | 2.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.6 | 2.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 11.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 2.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.5 | 9.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.5 | 5.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.5 | 6.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.5 | 3.0 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 7.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 2.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 1.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 16.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 1.9 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.5 | 1.9 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.5 | 5.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.5 | 99.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 8.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.5 | 1.4 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.5 | 6.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 5.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 2.2 | GO:0033041 | sweet taste receptor activity(GO:0033041) |
0.4 | 3.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 9.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 3.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 2.9 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 6.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.4 | 5.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 24.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 2.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 4.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 2.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 24.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.4 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 11.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.4 | 4.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 3.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.3 | 4.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 5.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 3.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.3 | 9.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 1.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.3 | 3.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 9.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 5.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 10.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 17.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.3 | 1.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 6.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 5.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 3.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.3 | 4.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 1.0 | GO:0031433 | telethonin binding(GO:0031433) |
0.2 | 0.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 4.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 7.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.7 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 3.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 4.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 2.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.7 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.2 | 1.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 7.0 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 7.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 14.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.2 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 1.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 3.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 0.6 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.2 | 0.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 1.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 6.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 2.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 8.4 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.2 | 1.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 1.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.2 | 3.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 2.1 | GO:0098919 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of synapse(GO:0098918) structural constituent of postsynaptic density(GO:0098919) |
0.2 | 0.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 3.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 6.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 9.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 52.7 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.9 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.1 | 13.4 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.1 | 1.7 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.1 | 2.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 3.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 5.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 3.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 1.9 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 2.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 51.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.5 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 1.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.1 | 1.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 62.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.5 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 5.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 1.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 3.6 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 1.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 1.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.7 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.6 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.0 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.4 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 107.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
2.4 | 133.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
1.1 | 49.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.9 | 21.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 32.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.8 | 36.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.8 | 120.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.7 | 11.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.7 | 12.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 28.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 25.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.6 | 143.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 13.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.6 | 10.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 8.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 10.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 19.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.5 | 2.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.5 | 4.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 25.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 3.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 4.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 5.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 15.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 2.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 10.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 2.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 4.2 | ST ADRENERGIC | Adrenergic Pathway |
0.2 | 10.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 13.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 5.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 6.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 3.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 8.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 3.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 4.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 3.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 4.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 145.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
6.4 | 57.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
4.9 | 48.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
4.5 | 152.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
3.4 | 30.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
3.3 | 56.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.5 | 48.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.2 | 37.3 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.2 | 85.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.1 | 37.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
2.0 | 8.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.9 | 57.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.9 | 74.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.8 | 45.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.8 | 26.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.6 | 52.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.5 | 19.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.5 | 27.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
1.4 | 40.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.3 | 33.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.3 | 26.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.2 | 17.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.2 | 16.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.2 | 16.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.1 | 16.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.1 | 52.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.0 | 28.7 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
1.0 | 16.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.0 | 10.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
1.0 | 11.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
1.0 | 16.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.9 | 10.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.9 | 26.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.9 | 18.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 15.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.8 | 17.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 12.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 8.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 10.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.6 | 13.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.6 | 17.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 6.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.6 | 10.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.5 | 9.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 3.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 3.0 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
0.5 | 7.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.5 | 7.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 68.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.5 | 2.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 4.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.4 | 7.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 11.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 7.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 0.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 14.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.4 | 6.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 1.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.3 | 9.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 3.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 4.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 9.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 11.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 12.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 5.0 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 6.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.3 | 4.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 3.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 2.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 16.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 3.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 3.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 5.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 1.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 4.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.2 | 3.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 4.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 23.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 4.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.2 | 2.4 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 4.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 5.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 5.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 5.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 2.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 6.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.0 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 2.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |